findmyKOL

Melissa Willis

Basic profile

University of Iowa

ORCIDNPI
RegionIowa City, IA · MidwestSpecialtyDermatologyFocusDermatology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Melissa Willis is a Dermatology physician affiliated with University of Iowa. OpenAlex indexes 15 publications with 633 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
15publications

Distinct works indexed by OpenAlex, matched via ORCID.

633citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    32.3%
    Azole Antifungal11.9%
    Ketoconazole100%
    Part D98 patients
    Tetracycline-class Drug9.1%
    Doxycycline Monohydrate100%
    Part D34 patients

    + 4 more classes in this area

  • Dermatology

    20.7%
    Corticosteroid13.6%
    Triamcinolone Acetonide95%Fluocinolone Acetonide5%
    Part D<11 patients
    Interleukin-4 Receptor alpha Antagonist4%
    Dupixent Pen100%
    Part D<11 patients

    + 3 more classes in this area

  • Sensory organs

    14.6%
    Corticosteroid14.6%
    Clobetasol Propionate57%Hydrocortisone35%Betamethasone Diprop Augmented8%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”